R&D

Asian biotechs to look beyond Asia for growth

Asian biotechs to look beyond Asia for growth

Written by on December 16, 2014 in Partnering & Investment, Research & Development with 0 Comments

Earlier this year at BioPharma Asia Convention, when we spoke to some speakers about their thoughts on the key growth strategy that Asian biotech companies should adopt, there seemed to be a unanimous agreement that looking beyond Asia is the way to go. “Biotech companies in Asia have to think globally, and link globally. “ […]

Continue Reading

Spotlight back on Antibiotics Market

Spotlight back on Antibiotics Market

Thought to be undervalued and overshadowed by the bigger revenue draw from blockbuster drug manufacturing, Merck’s ($MRK) recent acquisition of Cubist ($CBST) might have placed a spotlight back to the Antibiotics Market. Unlike its compatriots in the biologic therapeutics market, antibiotics target specifically on bacterial infections. More often than not, the efficacy of antibiotics decreases […]

Continue Reading

Drug Discovery

Breast Cancer Awareness Month and cancer innovation

Breast Cancer Awareness Month and cancer innovation

Written by on October 29, 2014 in Drug Discovery with 0 Comments

With it being Breast Cancer Awareness Month this October, it seemed a good time to tell you about a new project we are working on and why.  According to Cancer Research UK, more than 1 in 3 people in the UK will develop some form of cancer during their lifetime. I come from a large […]

Continue Reading

Landsteiner Scientific Discute los Biocomparables y la Medicina Genómica

Landsteiner Scientific Discute los Biocomparables y la Medicina Genómica

Written by on October 27, 2014 in Drug Discovery, Reports, Research & Development with 0 Comments

Francisco Kuri Breña, Director de Nuevos Desarrollos a Landsteiner Scientific, fue ponente al evento BioPharma México, del año pasado, donde dió una presentación en los biocomparables y la medicina genómica. Francisco ha trabajado en el desarrollo de nuevos productos sintéticos y biotecnológicos así como en proyectos de medicina genómica en la misma empresa. Realizó estudios […]

Continue Reading

Clinical Trials

Partnering for success: Collaboration and best practice for clinical trial efficiency

Partnering for success: Collaboration and best practice for clinical trial efficiency

Written by on December 15, 2014 in Clinical Trials, Reports with 0 Comments

At the 2014 Clinical Outsourcing & Partnering World event, Bert Hartog, Janssen, gave a presentation on “Partnering for success Collaboration and best practice for clinical trial efficiency”. Hartog’s presentation discusses traditional outsourcing and current vision, as well as focusing on essentials for success such as strategic partnership based on shared goals and intelligent suppliers. Download and […]

Continue Reading

Strategic Standards Implementations: How to Meet the Demands of a Plethora of Clinical Trial Sourcing Solutions

Strategic Standards Implementations: How to Meet the Demands of a Plethora of Clinical Trial Sourcing Solutions

Written by on December 15, 2014 in Clinical Trials, Reports with 0 Comments

  At the 2014 Clinical Innovation Congress, Jason Housley, Shire, gave a presentation on “Strategic Standards Implementations: How to Meet the Demands of a Plethora of Clinical Trial Sourcing Solutions”. Download and learn: Purely competitive outsourced models Preferred providers Partnerships / alliances In-house models Standards solutions Other considerations The bigger picture – Industry standardisation and the […]

Continue Reading

Manufacturing

Download White Paper : Single Use Technology specifically designed for microbial fermentation

Download White Paper : Single Use Technology specifically designed for microbial fermentation

Written by on December 9, 2014 in Cell Culture, Manufacturing with 0 Comments

Single Use Technology is pretty much the one of the most talked about trend in the BioPharmaceutical Space. Within a doubt, this is one topic that has been constantly asked for by our attendees across the BioPharma Asia Pacific events. As we move quickly into the next phase for the BioPharma Asia Convention 2015, we […]

Continue Reading

Who are the top 4 Players in 3D Antibody Characterization?

Who are the top 4 Players in 3D Antibody Characterization?

Written by on November 25, 2014 in Antibodies, Manufacturing with 1 Comment

Who are the top 4 Players in 3D Antibody Characterization? Therapeutic antibody engineering has been around for years. So what is keeping the number of therapeutic antibody treatments so relatively low when compared to small molecules and other types of therapeutics? Antibodies, and their therapeutic derivatives such as antibody-drug conjugates (ADCs), are complex, multi-faceted molecules […]

Continue Reading

Regulation & Compliance

Implementing an Enterprise Wide LMS

Implementing an Enterprise Wide LMS

Some time back, not too long ago, the North American headquarters of a global Pharmaceutical company acquired several business units, and in an effort to standardize roles and consolidate training and qualifications, company leaders were seeking a single Learning Management System (LMS) to unify its eight operating companies and 7,000 employees. Leading the LMS evaluation […]

Continue Reading

Private Cord Blood Banks vs Public Health: Is it Time to Bury the Hatchet?

Private Cord Blood Banks vs Public Health: Is it Time to Bury the Hatchet?

Written by on October 27, 2014 in Regulation and Compliance with 0 Comments

Can private cord blood banks ever work in synergy with public and national health services? Cord blood is the blood that remains in the placenta and umbilical cord after a baby is born. It is rich in stem cells, which can help to cure many life threatening diseases. The stem cells found in cord blood […]

Continue Reading

Pricing & Market Access

Italy: update on the reform agenda

Italy: update on the reform agenda

Written by on December 10, 2014 in Pricing & Market Access, Reports with 0 Comments

At World Pharma Pricing & Market Access Congress 2014, Dr Giovanni Tafuri, AIFA, gave a presentation on  “Italy: update on the reform agenda” Tafuri’s presentation discusses his thoughts on how to solve current problems like how to balance fast market access with available resources, how to harmonize market access across regions, and  how to cope with […]

Continue Reading

How Do You Demonstrate Value For Innovative Drugs To Payers?

How Do You Demonstrate Value For Innovative Drugs To Payers?

Written by on December 7, 2014 in Pricing & Market Access, Reports with 0 Comments

  At Evidence EU 2014,  Prof. Dr. Markus Kosch, Pfizer Oncology, Portfolio Lead Europe, Africa/Middle East, Pfizer, gave a presentation on “How Do You Demonstrate Value For Innovative Drugs To Payers?” Download and learn: Value of innovation to public health PFS vs. OS the “wrong comparator” –can STC help? Real world data Download presentation Found […]

Continue Reading

Engagement & Marketing

New Age Project Management

New Age Project Management

Traditionally, Project Management was all about cost, timeline and success of that project. But most often than not, there are dependencies for a project – either upstream or downstream. These dependencies become all the more important when (mostly when and not if) the project deviates from cost ortimeline. On what basis should the decision makers tasked with bringing back the […]

Continue Reading

3 ways to use social media as a healthcare professional

3 ways to use social media as a healthcare professional

Written by on October 24, 2014 in Engagement & Communications, Featured on app with 0 Comments

Whether you are a healthcare clinician or patient, biotech CEO or an academic professor, there is a social media platform for you. Those who know me will know that I am a big advocate of using different social media platforms to engage with your communities. That said, what can be deemed as productive can often […]

Continue Reading

Partnering & Investment

Promising scale and market success for cell therapies after large financial injection

Promising scale and market success for cell therapies after large financial injection

Written by on September 19, 2014 in Featured on app, Partnering & Investment with 0 Comments

In a report released this week, by BCC Research, it was forecasted that the global market for stem cells (including cell therapies) is to reach US $10.6 billion in 2018. However with currently no medicines, based on stem cells, having yet received marketing authorisation from the EMA*, or the FDA*, how are we going to get there? […]

Continue Reading

An investor perspective and analysis of the stem cell & regenerative medicine sector

An investor perspective and analysis of the stem cell & regenerative medicine sector

Written by on September 12, 2014 in Partnering & Investment, Regenerative Medicine with 0 Comments

Dr. Navid Malik B.Sc. M.Sc. MBA, Cenkos joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to present on ‘An investor perspective and analysis of the stem cell & regenerative medicine sector’ Download this presentation now to find out: Cenkos Securities’ focus on Life Sciences Longer-term sector returns have been very […]

Continue Reading

Top
Geolocation